Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects June 15, 2011
In Vivo Imaging of Cerebral Serotonin Transporter and Serotonin 2A Receptor Binding in MDMA and Hallucinogen Users June 6, 2011
The 5-HT2A/1A Agonist Psilocybin Disrupts Modal Object Completion Associated with Visual Hallucinations March 1, 2011
Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens January 20, 2011
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer January 3, 2011
Psychobiology of Drug-Induced Religious Experience: From the Brain 'Locus of Religion' to Cognitive Unbinding November 13, 2010
